Dry Eye Assessment and Management Study

PHASE3CompletedINTERVENTIONAL
Enrollment

535

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

September 5, 2017

Study Completion Date

January 31, 2020

Conditions
Dry Eye
Interventions
DRUG

Omega-3 supplements

2000 mg EPA and 1000 mg DHA per day

DRUG

Placebo

Olive oil gelcaps manufactured to mimic Omega-3 gelcaps

Trial Locations (27)

10029

Icahn School of Medicine at Mount Sinai, New York

14642

Universtity of Rochester-Flaum Eye Institute, Rochester

19104

Scheie Eye Institute, University of Pennsylvania, Philadelphia

27603

Oculus Research at Garner at Eyecarecenter, Raleigh

30260

Eye Care Centers Management, Inc., Morrow

38104

Southern College of Optometry, Memphis

44106

Case Western Reserve University, Cleveland

44240

Northeast Ohio Eye Surgeons, Kent

46260

Price Vision Group, Indianapolis

48105

University of Michigan Kellogg Eye Center, Ann Arbor

53405

The Eye Centers of Racine and Kenosha, Racine

55431

Minnesota Eye Consultants, P.A., Bloomington

60612

University of Illinois Hospital & Health Sciences, Chicago

63141

Mulqueeny Eye Centers, Creve Coeur

64111

Tauber Eye Center, Kansas City

64133

Silverstein Eye Centers, Kansas City

66208

KU Eye Center, Prairie Village

85254

Stephen Cohen, OD PC, Scottsdale

85259

Mayo Clinic Arizona, Scottsdale

90505

Wolstan and Goldberg Eye Associates, Torrance

91702

Milton M. Hom, OD, FAAO, Azusa

92056

Pendleton Eye Center, Oceanside

94720

University of California, Berkeley, Berkeley

Unknown

Shettle Eye Research, Largo

02111

Tufts Medical Center, Boston

02114

Massachusetts Eye and Ear Infirmary, Boston

01890

Clinical Eye Research of Boston, Winchester

All Listed Sponsors
collaborator

National Eye Institute (NEI)

NIH

lead

University of Pennsylvania

OTHER

NCT02128763 - Dry Eye Assessment and Management Study | Biotech Hunter | Biotech Hunter